HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid Arthritis.

AbstractOBJECTIVE:
Rheumatoid arthritis (RA) is a chronic disease leading to joint destruction. Although many studies have addressed factors potentially correlated with the speed of joint destruction, less attention has been paid to the distribution of joint destruction in patients with RA. In this study, destruction of the hand bones in patients with RA was classified into 2 anatomic subgroups, the fingers and the non-fingers, with the aim of analyzing which factors are associated with destruction of the finger joints.
METHODS:
A total of 1,215 Japanese patients with RA were recruited from 2 different populations. The degree of joint destruction was assessed using the total modified Sharp/van der Heijde score (SHS) of radiographic joint damage. The SHS score of joint damage in the finger joints was used as the dependent variable, and the SHS score in the non-finger joints was used as a covariate. Age, sex, disease duration, smoking, C-reactive protein level, treatment for RA, and positivity for and levels of anti-citrullinated protein antibodies and rheumatoid factor (RF) were evaluated as candidate correlates. Overall effect sizes were assessed in a meta-analysis. In addition, associations observed in the Japanese patients were compared to those in a cohort of 157 Dutch RA patients in the BeSt study (a randomized, controlled trial involving 4 different strictly specified treatment strategies for early RA).
RESULTS:
Not surprisingly, disease duration in Japanese patients with RA was associated with the finger SHS score (P ≤ 0.00037). Both positivity for and levels of RF showed significant associations with the finger SHS score after adjustment for covariates (P = 0.0022 and P = 8.1 × 10(-7) , respectively). These associations were also true in relation to the time-averaged finger SHS score. An association between RF positivity and the finger SHS score was also observed in Dutch patients with RA in the BeSt study (P = 0.049).
CONCLUSION:
Positivity for and levels of RF are associated with finger joint destruction independent of non-finger joint destruction and other covariates. Our findings suggest that there are different mechanisms of joint destruction operating in the finger joints of patients with RA.
AuthorsChikashi Terao, Noriyuki Yamakawa, Koichiro Yano, Iris M Markusse, Katsunori Ikari, Shinji Yoshida, Moritoshi Furu, Motomu Hashimoto, Hiromu Ito, Takao Fujii, Koichiro Ohmura, Kosaku Murakami, Meiko Takahashi, Masahide Hamaguchi, Yasuharu Tabara, Atsuo Taniguchi, Shigeki Momohara, Soumya Raychaudhuri, Cornelia F Allaart, Hisashi Yamanaka, Tsuneyo Mimori, Fumihiko Matsuda
JournalArthritis & rheumatology (Hoboken, N.J.) (Arthritis Rheumatol) Vol. 67 Issue 12 Pg. 3113-23 (Dec 2015) ISSN: 2326-5205 [Electronic] United States
PMID26245322 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015, American College of Rheumatology.
Chemical References
  • Antirheumatic Agents
  • Autoantibodies
  • HLA-DRB1 Chains
  • Peptides, Cyclic
  • cyclic citrullinated peptide
  • Rheumatoid Factor
  • Methotrexate
Topics
  • Adult
  • Aged
  • Antirheumatic Agents (therapeutic use)
  • Arthritis, Rheumatoid (diagnostic imaging, drug therapy, genetics, immunology)
  • Asian People
  • Autoantibodies (immunology)
  • Cohort Studies
  • Disease Progression
  • Female
  • Finger Joint (diagnostic imaging)
  • Foot Joints (diagnostic imaging)
  • HLA-DRB1 Chains (genetics)
  • Hand Joints (diagnostic imaging)
  • Humans
  • Japan
  • Linear Models
  • Male
  • Methotrexate (therapeutic use)
  • Middle Aged
  • Netherlands
  • Peptides, Cyclic (immunology)
  • Radiography
  • Rheumatoid Factor (immunology)
  • Severity of Illness Index
  • White People

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: